Skip to main content

ENCISION INC

corporate_fare Company Profile

ENCISION INC

ECIA·OTC·Healthcare·CIK 0000930775

Encision Inc. is a medical device company based in Boulder, Colorado, that develops and markets technology for minimally invasive surgery. The company's primary products are its patented Active Electrode Monitoring (AEM) Surgical Instruments. These instruments are designed to address the risk of inadvertent collateral tissue damage during laparoscopic surgery, which can occur with conventional monopolar electrosurgery instruments. AEM technology aims to prevent patient injury from stray monopolar energy by continuously monitoring the flow of electrosurgical current. The AEM Surgical Instruments incorporate a proprietary shield and connect to an Active Electrode Monitor. These instruments are comparable to conventional instruments in size, shape, ergonomics, and functionality. Encision's technology allows surgeons to perform electrosurgical procedures more safely, effectively, and economically.

ENCISION INC (OTC:ECIA) is a publicly traded company in the Healthcare sector. Wiseek has independently scored 3 items for ECIA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-05-04, rated 9/10. Across its 3 most recent items scored 7 or higher, the top rating is 9/10, with 3 rated 8 or above. Recent SEC coverage for ECIA spans 8-K.

Recent high-impact activity:

  • Encision Stock Trading Halted as Company Deregisters from SEC Reporting
  • Encision Returns to Operating Profitability in March, Forecasts Q1 Profit Despite Sales Decline
  • Encision Inc. to Deregister Common Stock, Suspend SEC Reporting

Financial Snapshot

Fiscal year ended March 31, 2025
Revenue
$6.56M
Net Income
-$220.2K
Diluted EPS
-$0.02
Op. Cash Flow
-$54.95K
Free Cash Flow
-$109.36K
Gross Profit
$3.51M
Operating Income
-$171.98K
Cash & Equivalents
$257.43K
Debt / Equity
0.00×
Net Margin
-3.4%
Shares Outstanding
11.88M sh
Source: 10-K · filed 2025-07-10 · accession 0001079973-25-001132

Short Interest & Short Volume

171.50 days to cover

FINRA reported short interest of 3,430 shares in ECIA as of the September 15, 2026 settlement, unchanged from the prior period — about 171.5 days to cover at its recent average daily volume. On September 30, 2026, 100.0% of ECIA volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)3,430 shares as of September 15, 2026
Change vs prior period 0.0%
Days to cover171.50 at avg daily volume of 20
Daily short volume (FINRA facilities)100.0% of 26,466 shares on September 30, 2026

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

$0.0115 -0.03% today
52-week range · as of 2026-01-29 $0.0115 – $0.75
Market cap
$194.12K
Volume
26.5K (1.5× avg)
3-mo avg 17.5K
Live data · 2026-10-04 06:34 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ECIA - Latest Insights

ECIA
May 04, 2026, 10:25 AM EDT
Source: Access Newswire
Importance Score:
9
Price at Filing: $0.201
Real-time Price: $0.0115 info
Change: -$0.1895 (-94%) info
Market Cap: $194.116K info
ECIA
Apr 13, 2026, 11:15 AM EDT
Source: Access Newswire
Importance Score:
8
Price at Filing: $0.110
Real-time Price: $0.0115 info
Change: -$0.0985 (-90%) info
Market Cap: $194.116K info
ECIA
Jan 29, 2026, 9:00 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.189
Real-time Price: $0.0115 info
Change: -$0.1775 (-94%) info
Market Cap: $194.116K info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets